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Dear Editor, shown to cause all arrhythmias by focal mechanisms,
We read with great interest the study by Becker et al. [1] suggesting abnormal automaticity and/or triggered activity
in which they analyzed the three-dimensional activation as underlying mechanism. Furthermore, the arrhythmias
patterns of ventricular arrhythmias induced by endothelin-1 originated mostly from the left ventricular subendocardium
(ET-1) in comparison with ischemia-induced arrhythmias. in both groups. The higher total number of arrhythmia
In order to support the hypothesis that ET-1 exerts an episodes, prolonged conduction time and refractoriness,
intrinsic arrhythmogenic effect which is not attributable to and involvement of macroreentrant mechanisms in the
ischemia, the authors investigated the electrophysiologic maintenance of some tachycardia episodes in the ligation
effects and the mechanism of induced ventricular arrhyth- group only suggests a more significant degree of ischemia,
mias after intracoronary administration of ET-1, as com- which is to be expected. The increased prevalence of right
pared to those caused by ligation of the left anterior ventricular foci associated with increased duration of ET-1
descending artery. This study provides substantial infor- infusion was explained by systemic recirculation of the
mation concerning proarrhythmic effects of ET-1 in vivo, agent. However, as the early pioneering work by de Nucci
and is of considerable interest to both clinical and basic et al. showed, circulating ET-1 is substantially removed by
electrophysiologists. the lungs and other organs [3]. Finally, it is well known
The findings are in accordance with the results of some that ventricular arrhythmias occur in two phases associated
previously published reports which demonstrated occur- with distinct changes in the electrical tissue properties after
rence of severe ventricular arrhythmias during ET-1 ad- occlusion of a major coronary artery in dogs, and the
ministration even without a substantial reduction in cor- incidence of the arrhythmias may vary considerably be-
onary blood flow, any alterations on surface ECG, is- cause of marked variation in preexisting collaterals [4].
chemic thermographic changes, or elevations in coronary Therefore, interpretation of the results of this comparative
sinus lactate concentrations [2]. Nevertheless, the topic analysis must be made with great caution.
remains to be controversial, and we believe that the The mechanisms by which ET-1 promotes the develop-
findings do not suffice to conclude that ET-1 is directly ment of arrhythmias may include prolongation and in-
arrhythmogenic for several reasons: First, using this meth- creased dispersion of monophasic action potential duration,
odology the authors cannot exclude the possibility that development of early after depolarizations, involvement of
21 1ET-1 infusion at a dose of 60 pmol /min may cause Ca /K channels, generation of inositol triphosphate,
1 1
myocardial ischemia. In view of the peptide’s marked acidosis, stimulation of the Na /H exchanger, and
vasoconstrictive potency, it is difficult to rule out some augmentation of cellular injury. However, all these mecha-
degree of accompanying regional, if not global, ischemia. nisms are all also activated by ischemia alone. Certainly, it
Secondly, ET-1 and coronary ligation were similarly is desirable to demonstrate a primary arrhythmogenic
effect of ET-1, which may open a new era in the field of
antiarrhythmic therapy. However, conclusive data is*Corresponding author. Tel.: 41-1-255-1111; fax: 141-1-255-4597.
E-mail address: karduf@usz.unizh.ch (F. Duru) needed to prove the hypothesis, and it will be difficult to
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